Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1
Copyright © 2023 by The American Association of Immunologists, Inc..
Multistep mast cell desensitization blocks the release of mediators following IgE crosslinking with increasing doses of Ag. Although its in vivo application has led to the safe reintroduction of drugs and foods in IgE-sensitized patients at risk for anaphylaxis, the mechanisms of the inhibitory process have remained elusive. We sought to investigate the kinetics, membrane, and cytoskeletal changes and to identify molecular targets. IgE-sensitized wild-type murine (WT) and FcεRIα humanized (h) bone marrow mast cells were activated and desensitized with DNP, nitrophenyl, dust mites, and peanut Ags. The movements of membrane receptors, FcεRI/IgE/Ag, actin, and tubulin and the phosphorylation of Syk, Lyn, P38-MAPK, and SHIP-1 were assessed. Silencing SHIP-1 protein was used to dissect the SHIP-1 role. Multistep IgE desensitization of WT and transgenic human bone marrow mast cells blocked the release of β-hexosaminidase in an Ag-specific fashion and prevented actin and tubulin movements. Desensitization was regulated by the initial Ag dose, number of doses, and time between doses. FcεRI, IgE, Ags, and surface receptors were not internalized during desensitization. Phosphorylation of Syk, Lyn, p38 MAPK, and SHIP-1 increased in a dose-response manner during activation; in contrast, only SHIP-1 phosphorylation increased in early desensitization. SHIP-1 phosphatase function had no impact on desensitization, but silencing SHIP-1 increased β-hexoxaminidase release, preventing desensitization. Multistep IgE mast cell desensitization is a dose- and time-regulated process that blocks β-hexosaminidase, impacting membrane and cytoskeletal movements. Signal transduction is uncoupled, favoring early phosphorylation of SHIP-1. Silencing SHIP-1 impairs desensitization without implicating its phosphatase function.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:210 |
---|---|
Enthalten in: |
Journal of immunology (Baltimore, Md. : 1950) - 210(2023), 6 vom: 15. März, Seite 709-720 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Adnan, Ather [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 09.03.2023 Date Revised 01.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.4049/jimmunol.2100485 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353876763 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM353876763 | ||
003 | DE-627 | ||
005 | 20240108140409.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4049/jimmunol.2100485 |2 doi | |
028 | 5 | 2 | |a pubmed24n1245.xml |
035 | |a (DE-627)NLM353876763 | ||
035 | |a (NLM)36881903 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Adnan, Ather |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.03.2023 | ||
500 | |a Date Revised 01.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 by The American Association of Immunologists, Inc. | ||
520 | |a Multistep mast cell desensitization blocks the release of mediators following IgE crosslinking with increasing doses of Ag. Although its in vivo application has led to the safe reintroduction of drugs and foods in IgE-sensitized patients at risk for anaphylaxis, the mechanisms of the inhibitory process have remained elusive. We sought to investigate the kinetics, membrane, and cytoskeletal changes and to identify molecular targets. IgE-sensitized wild-type murine (WT) and FcεRIα humanized (h) bone marrow mast cells were activated and desensitized with DNP, nitrophenyl, dust mites, and peanut Ags. The movements of membrane receptors, FcεRI/IgE/Ag, actin, and tubulin and the phosphorylation of Syk, Lyn, P38-MAPK, and SHIP-1 were assessed. Silencing SHIP-1 protein was used to dissect the SHIP-1 role. Multistep IgE desensitization of WT and transgenic human bone marrow mast cells blocked the release of β-hexosaminidase in an Ag-specific fashion and prevented actin and tubulin movements. Desensitization was regulated by the initial Ag dose, number of doses, and time between doses. FcεRI, IgE, Ags, and surface receptors were not internalized during desensitization. Phosphorylation of Syk, Lyn, p38 MAPK, and SHIP-1 increased in a dose-response manner during activation; in contrast, only SHIP-1 phosphorylation increased in early desensitization. SHIP-1 phosphatase function had no impact on desensitization, but silencing SHIP-1 increased β-hexoxaminidase release, preventing desensitization. Multistep IgE mast cell desensitization is a dose- and time-regulated process that blocks β-hexosaminidase, impacting membrane and cytoskeletal movements. Signal transduction is uncoupled, favoring early phosphorylation of SHIP-1. Silencing SHIP-1 impairs desensitization without implicating its phosphatase function | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Actins |2 NLM | |
650 | 7 | |a Immunoglobulin E |2 NLM | |
650 | 7 | |a 37341-29-0 |2 NLM | |
650 | 7 | |a Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases |2 NLM | |
650 | 7 | |a EC 3.1.3.86 |2 NLM | |
650 | 7 | |a Phosphoric Monoester Hydrolases |2 NLM | |
650 | 7 | |a EC 3.1.3.2 |2 NLM | |
650 | 7 | |a Receptors, IgE |2 NLM | |
650 | 7 | |a Tubulin |2 NLM | |
650 | 7 | |a INPP5D protein, human |2 NLM | |
650 | 7 | |a EC 3.1.3.86 |2 NLM | |
700 | 1 | |a Acharya, Shree |e verfasserin |4 aut | |
700 | 1 | |a Alenazy, Leila A |e verfasserin |4 aut | |
700 | 1 | |a de Las Vecillas, Leticia |e verfasserin |4 aut | |
700 | 1 | |a Giavina Bianchi, Pedro |e verfasserin |4 aut | |
700 | 1 | |a Picard, Matthieu |e verfasserin |4 aut | |
700 | 1 | |a Calbache-Gil, Lucia |e verfasserin |4 aut | |
700 | 1 | |a Romero-Pinedo, Salvador |e verfasserin |4 aut | |
700 | 1 | |a Abadí A-Molina, Ana Clara |e verfasserin |4 aut | |
700 | 1 | |a Kerr, William |e verfasserin |4 aut | |
700 | 1 | |a Pedicone, Chiara |e verfasserin |4 aut | |
700 | 1 | |a Nagai, Jun |e verfasserin |4 aut | |
700 | 1 | |a Hollers, Eleanor |e verfasserin |4 aut | |
700 | 1 | |a Dwyer, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Castells, Mariana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of immunology (Baltimore, Md. : 1950) |d 1945 |g 210(2023), 6 vom: 15. März, Seite 709-720 |w (DE-627)NLM000018554 |x 1550-6606 |7 nnns |
773 | 1 | 8 | |g volume:210 |g year:2023 |g number:6 |g day:15 |g month:03 |g pages:709-720 |
856 | 4 | 0 | |u http://dx.doi.org/10.4049/jimmunol.2100485 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 210 |j 2023 |e 6 |b 15 |c 03 |h 709-720 |